Price sensitive because they've increased their ownership in Coridon, now Admedus Vaccines.
Ann: Admedus HSV-2 Phase II Study Interim Update, page-30
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
0.000(0.00%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $96.66K | 9.794K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 286 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.99 | 198 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |